Sunshine Biopharma (SBFM) filed a registration statement Monday for the potential sale of up to $100 million of its securities from time to time.
The filing covers the company's common stock, preferred stock, warrants, rights and units.
The company said it plans to use the net proceeds for general corporate purposes, including working capital.
Shares of Sunshine Biopharma were down 6.7% in recent Monday trading.
Price: 3.23, Change: -0.23, Percent Change: -6.65
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.